Tallaalka kansarka xubinta taranka dumarka

La qaybso Post this

Ma jirtaa xadka da'da ee lagu tallaalayo kansarka xubinta taranka dumarka?

Tallaalkii ugu horreeyay ee HPV ee la ansixiyay ee ka hortagga kansarka ilmo-galeenka ayaa si rasmi ah suuqa looga bilaabay. Taas ka hor, siyaabaha ugu muhiimsan ee looga hortagi karo kansarka ilmo-galeenka waxay ahayd baarista ilmo-galeenka. 
CCTV Finance ayaa hore u sheegtay in tallaalku yahay "Sirius" ee shirkadda dawooyinka ee Ingiriiska ee GlaxoSmithKline - qiimaha labada nooc ee laba nooc oo fayras ah (HPV-16 iyo HPV-18) oo sababi kara kansarka xubinta taranka dumarka iyo tallaalka ugu khatarta badan. 
Marka laga hadlayo bayaanka sheegaya in da'da ugu fiican ee talaalku yahay 9 ilaa 25 sano jir, Zhang Youzhong, oo ah ku xigeenka agaasimaha waaxda cudurada haweenka iyo Oncology, Isbitaalka Qilu ee Jaamacadda Shandong, ayaa ku sheegay wareysi uu la yeeshay Qilu Evening News in xitaa hadii uu dhamaado 25 sano jir, haddii uusan qabin fayraska HPV, ama uusan ku dhicin labada fayras ee aan kor ku soo xusnay welina waa la isku mudayaa. China’s annual kansarka ilma-mareenka cases account for more than 28% of the world’s, and it is one of the most common malignant tumors for women. Globally, cervical cancer is also the third most common cancer among women aged 15 to 44. 
Khabiirka: Waxa jira saddex xaaladood oo ka weyn da'da 25 sano. Waxa kale oo aad wici kartaa
bogga rasmiga ah ee Maamulka Cuntada iyo Dawooyinka si loo muujiyo in HPV Shiine yahay loo yaqaan  fayraska papilloma ee aadanaha. Inta badan noocyada hadda la yaqaan ee in ka badan 100 nooc ee HPV waa "khatar hoose" mana la xiriiraan kansarka ku dhaca makaanka afkiisa, laakiin 14 ka mid ah waxaa lagu sifeeyay inay yihiin "halis sare" iyo laba ka mid ah noocyada halista ugu sarreeya (HPV-16 Type iyo HPV- 18 nooc) wuxuu sababi karaa qiyaastii 70% kansarka xubinta taranka dumarka. 
Da'da ugu wanaagsan ee tallaalka tallaalka labada nooc "Cirius" markan waa 9 illaa 25 sano jir. Qaar badan oo ka mid ah shabakadaha net-ka ayaa muujiyay qoomamo. Ma la tallaali karaa dadka ka weyn 25 sano? 
Bishii Ogosto 3, Zhang Youzhong, oo ah ku xigeenka agaasimaha waaxda cudurada haweenka ee Qilu Hospital ee Jaamacadda Shandong, ayaa wareysi uu siiyay Qilu Evening News ku sheegay in 9-25 sano jir kaliya loo fahmi karo inuu yahay da'da ugu fiican ee tallaalka. Xaqiiqdii, waxaa jira saddex xaaladood oo weli tallaalkan lagu duri karo: midi waa inkasta oo uu ka weyn yahay 25 sano, uusan qabin fayraska HPV; midda kale waa inuu ku dhacay fayraska HPV, laakiin ma qabo laba nooc oo fayraska HPV ah, 16, 18; Tan saddexaadna waxay tahay inkasta oo HPV laqaaday oo nabarro hore oo kansarka xubinta taranka dumarka ah ay dhaceen, way bogsadeen oo waxay noqdeen daruur. 
Marka loo eego macluumaadka dadweynaha ee ay bixiso Maamulka Cuntada iyo Dawooyinka ee Dawladdu, infekshannada HPV waxay ku badan yihiin haweenka. Xogta ayaa muujineysa in marxalad gaar ah oo nolosha ah, 4tii dumar ahba 5 kamid ah ayaa cudurka qaadi doona. Haddii aad qabtid cudurka halista ah ee HPV, waxaa laga yaabaa inuu u gudbo heer aad u sarreeya oo ah dhaawacyada afka ilmo-galeenka ama xitaa isku beddelo kansarka xubinta taranka dumarka. 
HPV badanaa waxaa lagu kala qaadaa galmada, sidoo kale waxaa lagu kala qaadi karaa taabashada tooska ah: tusaale ahaan, ka dib taabashada shay ay gacanta ku hayaan HPV, waxaad u keeni kartaa fayraska xubnaha taranka inta lagu jiro musqusha ama maydhashada; ama haddii xubinta taranka ay soo gaadho HPV Waxyaabaha sida tuwaalada lagu maydho ayaa laga yaabaa inay ku dhacaan. 
Tallaalka afar-geesoodka ah ayaa la filayaa in lagu qoro xilligan. 
Sida laga soo xigtay CCTV Financial Reports, ilmo galeenka guud tallaalka kansarka waxa loo qaybiyaa laba, afar, iyo sagaal qiimo. Markan waxa la oggolaaday in lagu suuq galiyo dhul weynaha. Waa GlaxoSmithKline tallaalka HPV ee bivalent. 
Qiao Youlin, oo ah agaasimaha sheybaarka kansarka epidemiology ee Akadeemiyada Shiinaha ee Sayniska Caafimaadka, ayaa ku sheegay wareysi uu siiyay CCTV News in bishii Maajo ee sanadkan, tallaalka afar-geesoodka ah (oo ku saleysan tallaalka laba-cirifoodka ah, laba fayras oo HPV ah ayaa la bartilmaameedsaday, iyo da'da ku habboon) waa 20 ilaa 45 sano jir) Waxaa ogolaaday gobolka waxaana lafilayaa in lagu qoro dhamaadka sanadka. 
Marka la eego goorta ay dadweynuhu isticmaali karaan tallaalka sagaal-valent, Qiao Youlin wuxuu sheegay in tallaalka sagaal-valent uusan wali gelin tijaabooyin caafimaad, iyo waqtiga la filayo waa "aad u dheer." 
Talaalka HPV ma lagu dari doonaa caymiska caafimaadka mustaqbalka dhow? Zhao Fanghui, oo ah ku-xigeenka agaasimaha, borofisar iyo macalinka takhasuska ee Waaxda Cudurrada Cudurrada, Isbitaalka Kansarka, Akadeemiyada Shiinaha ee Sayniska Caafimaadka, ayaa rumeysan in aysan macquul ahayn in qiimaha tallaalka la dhimo iyadoo loo marayo tartanka suuqa, ka dibna waa la daboolayaa caymiska caafimaadka. 
Marka laga hadlayo tallaalada kansarka xubinta taranka dumarka, Maamulka Cuntada iyo Dawada ee Gobolka waxay xasuusisay in maadama ay jiraan in ka badan 10 nooc hoosaadyada sare ee fayraska HPV ee la xiriira kansarka ku dhaca makaanka afkiisa, talaalada ayaa kaliya lagu bartilmaameedsanayaa qaar ka mid ah, xitaa hadii la tallaalo, waa inay weli si joogto ah u Baadhitaan.

Ku soo Dhawo Wargeyskayaga

Hel wax cusub oo waligaa ha ka maqnaan blog ka Cancerfax

Inbadan Oo La Baadho

Daawaynta Unug ee CAR T ee Ku Salaysan Aadanaha: Horumarrada iyo Caqabadaha
Daaweynta T-Cell-ka Baabuurka

Daawaynta Unug ee CAR T ee Ku Salaysan Aadanaha: Horumarrada iyo Caqabadaha

Daawaynta Unugyada CAR-ku-salaysan ee bini-aadmigu waxa ay wax ka beddeshaa daawaynta kansarka iyada oo hidde ahaan wax ka beddeleysa unugyada difaaca bukaanka si ay u beegsato oo ay u burburiso unugyada kansarka. Ka faa'iidaysiga awoodda habka difaaca jidhka, daawayntani waxay bixiyaan daweyn awood leh oo shakhsi ahaaneed oo leh suurtagalnimada cafis waara ee noocyada kala duwan ee kansarka.

Fahamka Cytokine Release Syndrome: Sababaha, Calaamadaha, iyo Daaweynta
Daaweynta T-Cell-ka Baabuurka

Fahamka Cytokine Release Syndrome: Sababaha, Calaamadaha, iyo Daaweynta

Cytokine Release Syndrome (CRS) waa falcelin habdhiska difaaca oo inta badan ka dhasha daawaynta qaarkood sida immunotherapy ama daawaynta unugga CAR-T. Waxay ku lug leedahay sii-deynta xad-dhaafka ah ee cytokines, taasoo keenta calaamado u dhexeeya qandho iyo daal ilaa dhibaatooyin nafta halis gelin kara sida dhaawaca xubnaha. Maareyntu waxay u baahan tahay kormeer taxadar leh iyo xeelado faragelineed.

Ma u baahan tahay caawimaad? Kooxdayadu waxay diyaar u yihiin inay ku caawiyaan.

Waxaan u rajeynaynaa caafimaad deg-deg ah mid aad jeceshahay iyo mid kuu dhow.

Bilow sheekada
Waxaan nahay Online! Nala hadal!
Sawir koodka
Hello,

Ku soo dhawoow CancerFax!

CancerFax waa madal horudhac ah oo u heellan in lagu xidho shakhsiyaadka wajahaya kansarka heerka sare ee daawaynta unugyada sida CAR T-Cell therapy, daawaynta TIL, iyo tijaabooyinka caafimaad ee adduunka oo dhan.

Nala soo socodsii waxaan kuu qaban karno.

1) Daaweynta kansarka ee dibadda?
2) CAR T-Cell therapy
3) Tallaalka kansarka
4) La-talinta fiidiyowga ee khadka tooska ah
5) daawaynta Proton